Paul G. Rothberg, Ph.D.

Paul G. Rothberg, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 608
Rochester, NY 14642

Office: (585) 273-2229
Fax: (585) 273-5120

Research Bio

Dr. Rothberg's research focuses on deciphering the role of human genetic variation in the development of disease. Particular areas of focus include cancer and neurodegeneration. Current areas of investigation include studies on the molecular genetics of neuronal ceroid lipofuscinosis (Batten disease) in collaboration with the Batten Disease Clinical and Research Center, the early prediction of drug resistance in chronic myeloid leukemia, and the role of germline variation in the prognosis of prostate cancer.

Recent Journal Articles

Showing the 5 most recent journal articles. 87 available »

2016 Sep
Wang X, Stolla M, Ring BZ, Yang Q, Laughlin TS, Rothberg PG, Skinner K, G Hicks D. "p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?" Human pathology. 2016 Sep; 55:196-201. Epub 2016 May 28.
2016 Sep
Joseph L, Cankovic M, Caughron S, Chandra P, Emmadi R, Hagenkord J, Hallam S, Jewell KE, Klein RD, Pratt VM, Rothberg PG, Temple-Smolkin RL, Lyon E. "The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology." The Journal of molecular diagnostics : JMD. 2016 Sep; 18(5):605-19. Epub 2016 Aug 16.
2015 Jun 18
Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL. "Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells." British journal of haematology. 2015 Jun 18; Epub 2015 Jun 18.
2014 Jul 7
Tiwary S, Preziosi M, Rothberg PG, Zeitouni N, Corson N, Xu L. "ERBB3 is required for metastasis formation of melanoma cells." Oncogenesis. 2014 Jul 7; 3:e110. Epub 2014 Jul 07.
2014 Apr
Scott GA, Laughlin TS, Rothberg PG. "Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2014 Apr; 27(4):516-23. Epub 2013 Sep 13.

Current Appointments

Professor - Department of Pathology and Laboratory Medicine (SMD) - Primary


Clinical Molecular Genetics - American Board of Pathology


PhD | Molecular Biology | St Univ at Stony Brook1981
BA | Chemistry | Cuny Queens College1976

Post-Doctoral Training & Residency

Fellowship at Fox Chase Cancer Center03/01/1982 - 08/31/1985